As of 2025-05-19, the Intrinsic Value of Medistim ASA (MEDI.OL) is 117.13 NOK. This MEDI.OL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 213.00 NOK, the upside of Medistim ASA is -45.00%.
The range of the Intrinsic Value is 86.65 - 195.98 NOK
Based on its market price of 213.00 NOK and our intrinsic valuation, Medistim ASA (MEDI.OL) is overvalued by 45.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 86.65 - 195.98 | 117.13 | -45.0% |
| DCF (Growth 10y) | 110.80 - 247.11 | 149.08 | -30.0% |
| DCF (EBITDA 5y) | 97.26 - 181.21 | 127.23 | -40.3% |
| DCF (EBITDA 10y) | 115.64 - 214.98 | 150.82 | -29.2% |
| Fair Value | 52.29 - 52.29 | 52.29 | -75.45% |
| P/E | 142.56 - 183.60 | 164.46 | -22.8% |
| EV/EBITDA | 85.40 - 163.60 | 116.39 | -45.4% |
| EPV | 136.31 - 190.84 | 163.58 | -23.2% |
| DDM - Stable | 54.13 - 180.44 | 117.28 | -44.9% |
| DDM - Multi | 73.25 - 194.53 | 106.99 | -49.8% |
| Market Cap (mil) | 3,906.42 |
| Beta | 0.35 |
| Outstanding shares (mil) | 18.34 |
| Enterprise Value (mil) | 3,752.27 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.07% |
| Cost of Debt | 5.00% |
| WACC | 7.04% |